Cathie Wood’s ARK ETFs have recently made some notable moves in their portfolio. According to Investing.com, they have bought shares of CRISPR Therapeutics (CRSP) and BWX Technologies (BWXT), while selling off positions in Roblox (RBLX) and Rocket Lab (RKLB) stock.
CRISPR Therapeutics is a biotech company focused on gene editing technology, which aligns with ARK’s focus on disruptive innovation. BWX Technologies, on the other hand, is a nuclear technology company that provides services to the government and other customers.
On the selling side, Roblox is a popular online gaming platform that has seen a surge in users during the pandemic. However, ARK has decided to part ways with this stock, as well as Rocket Lab, a space technology company that recently went public.
Overall, Cathie Wood’s ARK ETFs continue to make strategic moves in their portfolio, staying true to their investment philosophy of seeking out innovative and high-growth companies.